Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 May;29(5):470-480.
doi: 10.1007/s11655-022-3584-x. Epub 2022 Sep 12.

Ayurveda and in silico Approach: A Challenging Proficient Confluence for Better Development of Effective Traditional Medicine Spotlighting Network Pharmacology

Affiliations
Review

Ayurveda and in silico Approach: A Challenging Proficient Confluence for Better Development of Effective Traditional Medicine Spotlighting Network Pharmacology

Rashmi Sahu et al. Chin J Integr Med. 2023 May.

Abstract

Coalescence of traditional medicine Ayurveda and in silico technology is a rigor for supplementary development of future-ready effective traditional medicine. Ayurveda is a popular traditional medicine in South Asia, emanating worldwide for the treatment of metabolic disorders and chronic illness. Techniques of in silico biology are not much explored for the investigation of a variety of bioactive phytochemicals of Ayurvedic herbs. Drug repurposing, reverse pharmacology, and polypharmacology in Ayurveda are areas in silico explorations that are needed to understand the rich repertoire of herbs, minerals, herbo-minerals, and assorted Ayurvedic formulations. This review emphasizes exploring the concept of Ayurveda with in silico approaches and the need for Ayurinformatics studies. It also provides an overview of in silico studies done on phytoconstituents of some important Ayurvedic plants, the utility of in silico studies in Ayurvedic phytoconstituents/formulations, limitations/challenges, and prospects of in silico studies in Ayurveda. This article discusses the convergence of in silico work, especially in the least explored field of Ayurveda. The focused coalesce of these two domains could present a predictive combinatorial platform to enhance translational research magnitude. In nutshell, it could provide new insight into an Ayurvedic drug discovery involving an in silico approach that could not only alleviate the process of traditional medicine research but also enhance its effectiveness in addressing health care.

Keywords: Ayurveda; challenge; confluence; effective therapeutics; in silico approach.

PubMed Disclaimer

Conflict of interest statement

Authors declare that they have no conflict of interest.

Similar articles

Cited by

References

    1. Park JJ, Beckman-Harned S, Cho G, et al. The current acceptance, accessibility and recognition of Chinese and Ayurvedic medicine in the United States in the public, governmental, and industrial sectors. Chin J Integr Med. 2012;18:405–408. doi: 10.1007/s11655-012-1110-2. - DOI - PubMed
    1. Ekins S, Mestres J, Testa B. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling. Br J Pharmacol. 2007;152:9–20. doi: 10.1038/sj.bjp.0707305. - DOI - PMC - PubMed
    1. Sliwoski G, Kothiwale S, Meiler J, et al. Computational methods in drug discovery. Pharmacol Rev. 2013;66:334–395. doi: 10.1124/pr.112.007336. - DOI - PMC - PubMed
    1. Singla RK, Bhat GV, Gonzalez-Diaz H. Thematic issue: from phytochemistry to medicinal chemistry: isolation, semisynthesis, evaluation and computational studies. Curr Top Med Chem. 2014;14:979–980. doi: 10.2174/1568026614666140324145723. - DOI
    1. Eduardo H, Bechelane M, Letícia CA, et al. Structure-based virtual screening: from classical to artificial intelligence. Front Chem. 2022;8:343. - PMC - PubMed

LinkOut - more resources